Internal Medicine, Rheumatology · Coral Gables, FL
NPI
1205925401
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
747 Ponce de Leon Blvd Ste 502
Coral Gables, FL, 33134
Phone (305) 442-1031
Groups this clinician bills Medicare through
Medicare paid, 2024
$67K
1,180 services
Medicare patients, 2024
137
Average age 79
Drug cost, 2024
$3.9M
6,251 prescriptions
Company payments, 2025
$1,748
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ramon Moreda was code 99214 (office e&m - established), 438 times for 123 patients. In total Ramon Moreda billed 1,180 services in 17 codes, and Medicare paid $67K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 438 | 123 | $105.19 | $46K |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 347 | 56 | $5.43 | $1,883 |
| 36415 Venipuncture Blood Collection | Office | 75 | 51 | $8.65 | $649 |
| 20610 Joint Injection | Office | 67 | 36 | $55.85 | $3,742 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 66 | 20 | $34.48 | $2,276 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 50 | 32 | $44.47 | $2,223 |
| 96401 Chemotherapy Administration | Office | 46 | 33 | $58.96 | $2,712 |
| 20552 Musculoskeletal | Office | 42 | 22 | $43.66 | $1,834 |
| 99204 Office E&M - New | Office | 29 | 29 | $141.14 | $4,093 |
By year: 2022 $83K for 1,461 services; 2023 $101K for 1,834 services; 2024 $67K for 1,180 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 75 | 51 | $8.65 | $649 |
Medicare prescription drug claims, 2024
In 2024, the drug Ramon Moreda prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 1,033 prescriptions and refills. In total Ramon Moreda wrote 6,251 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 1,033 | 1,154 | 175 | $6,883 |
| Hydroxychloroquine Sulfate Generic | 993 | 1,049 | 212 | $7,579 |
| Prednisone Generic | 672 | 701 | 133 | $3,955 |
| Prolia Denosumab | 427 | 2,562 | 296 | $742K |
| Folic Acid Generic | 410 | 446 | 93 | $840 |
| Alendronate Sodium Generic | 365 | 421 | 89 | $981 |
| Gabapentin Generic | 346 | 364 | 87 | $2,092 |
| Lidocaine Generic | 307 | 310 | 63 | $16K |
| Tramadol Hcl Generic | 236 | 236 | 61 | $1,057 |
| Tramadol Hcl-Acetaminophen Tramadol Hcl/Acetaminophen | 159 | 159 | 42 | $1,641 |
| Savella Milnacipran Hcl | 137 | 139 | 43 | $66K |
| Diclofenac Sodium Generic | 124 | 127 | 48 | $4,187 |
| Humira(Cf) Pen Adalimumab | 87 | 87 | 12 | $604K |
| Mycophenolate Mofetil Generic | 68 | 68 | 17 | $6,124 |
| Calcitonin-Salmon Calcitonin,salmon,synthetic | 59 | 63 | 15 | $79K |
Brand drugs: - claims; generic drugs: 5,040 claims; opioid claims: 395.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ramon Moreda $1,748 ($1,748 in general payments such as food, travel and fees) from 8 companies. The largest payer was Ucb Sa with $1,142.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.